These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21448900)

  • 1. Safety profile of oseltamivir during the 2009 influenza pandemic.
    Donner B; Bader-Weder S; Schwarz R; Peng MM; Smith JR; Niranjan V
    Pharmacoepidemiol Drug Saf; 2011 May; 20(5):532-43. PubMed ID: 21448900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of compliance with oseltamivir phosphate therapy in Japan.
    Ushijima K; Higuchi S; Fujimura A
    Am J Ther; 2009; 16(1):8-10. PubMed ID: 22573053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Compliance and safety of oseltamivir treatment in children and infants less than one year of age].
    Tasher D; Bishop B; Stein M; Somekh E
    Harefuah; 2012 Aug; 151(8):450-4, 499. PubMed ID: 23350287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients.
    Ison MG; Szakaly P; Shapira MY; Kriván G; Nist A; Dutkowski R
    Antivir Ther; 2012; 17(6):955-64. PubMed ID: 22728756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza and oseltamivir phosphate (Tamiflu) in infants: what you need to know.
    Mortada M; Neuenschwander P; Tekko SS
    Pediatr Nurs; 2014; 40(1):16-20. PubMed ID: 24757915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
    Cao B; Li XW; Mao Y; Wang J; Lu HZ; Chen YS; Liang ZA; Liang L; Zhang SJ; Zhang B; Gu L; Lu LH; Wang DY; Wang C;
    N Engl J Med; 2009 Dec; 361(26):2507-17. PubMed ID: 20007555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent jump case in Japan associated with influenza but not oseltamivir.
    Terada K; Kawai Y; Monju A; Wakabayashi T; Ouchi K
    Pediatr Infect Dis J; 2008 Jan; 27(1):88-9. PubMed ID: 18162953
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.
    Smith JR; Sacks S
    Int J Clin Pract; 2009 Apr; 63(4):596-605. PubMed ID: 19335705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing in a pandemic: best use of oseltamivir in paediatric intensive care.
    Seale AC; Toussaint FS; Finn A; Fraser JI
    Arch Dis Child; 2011 Sep; 96(9):902-3. PubMed ID: 20702390
    [No Abstract]   [Full Text] [Related]  

  • 10. Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
    Greener M
    Nurs Times; 2009 Sep 1-7; 105(34):22. PubMed ID: 19788111
    [No Abstract]   [Full Text] [Related]  

  • 11. ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia.
    L'Huillier AG; Ing Lorenzini K; Crisinel PA; Rebsamen MC; Fluss J; Korff CM; Barbe RP; Siegrist CA; Dayer P; Posfay-Barbe KM; Desmeules JA;
    Pharmacogenomics; 2011 Oct; 12(10):1493-501. PubMed ID: 21902503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The 2009/2010 pandemic].
    Schaberg T; Burger R
    Pneumologie; 2010 Dec; 64(12):755-67; quiz 768. PubMed ID: 21128196
    [No Abstract]   [Full Text] [Related]  

  • 13. Survey of Japanese infants younger than 3 months who were treated with oseltamivir for influenza: safety of oseltamivir treatment.
    Morioka I; Nonoyama S; Tanaka-Taya K; Ihara T; Sugaya N; Ueta I; Kumagai T; Okada K; Hosoya M; Okabe N; Morishima T;
    Scand J Infect Dis; 2012 Aug; 44(8):605-9. PubMed ID: 22497443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oseltamivir: cutaneous and neurological adverse effects in children.
    Prescrire Int; 2006 Oct; 15(85):182-3. PubMed ID: 17128526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiaries.
    Mosholder AD; Racoosin JA; Young S; Wernecke M; Shoaibi A; MaCurdy TE; Worrall C; Kelman JA
    Ann Pharmacother; 2013 Nov; 47(11):1420-8. PubMed ID: 24285759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance to oseltamivir and subsequent occurrence of self-reported adverse drug reactions among nursery and primary school children following exposure to Influenza A(H1N1)v.
    van Velzen E; Hutchinson S; Penrice G; Ahmed S; McMenamin J
    Scott Med J; 2011 May; 56(2):120. PubMed ID: 21670140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
    Nakamura K; Schwartz BS; Lindegårdh N; Keh C; Guglielmo BJ
    Clin Infect Dis; 2010 Apr; 50(7):e47-9. PubMed ID: 20192728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
    Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
    J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan.
    Yang JR; Huang YP; Lin YC; Su CH; Kuo CY; Hsu LC; Wu HS; Liu MT
    Antiviral Res; 2010 Dec; 88(3):256-62. PubMed ID: 20869989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pandemic influenza vaccines and neuraminidase inhibitors: efficacy and side effects.
    Bijl D
    Int J Risk Saf Med; 2011; 23(2):65-71. PubMed ID: 21673413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.